Accurate and Early Diagnosis for Lupus and Connective Tissue Disease. Connective tissue diseases (CTDs) can be very hard to diagnose early because symptoms can be vague, inconsistent and/or attributed to other illnesses. AVISE CTD combines AVISE Lupus, a 10-marker diagnostic test designed to help rule-in or rule-out lupus, with an expanded connective tissue disease panel to aid in the differential diagnosis of other connective tissue diseases. When combined with your provider's clinical assessment, AVISE CTD can provide the information necessary to help make the right diagnosis. If you're ready to start dealing with the real cause of your symptoms don't wait. Request your AVISE CTD conversation guide to help you speak to your provider about the AVISE CTD test.
Exagen
Exagen Inc. is a patient-focused and discovery-driven commercial-stage life sciences company that serves as a global leader in autoimmune disease testing. The company is known for its expertise in autoimmune disease diagnostics and offers a range of tests in this field. They are dedicated to improving the diagnosis and management of autoimmune conditions.
Their diagnostic tests are designed to assist healthcare professionals in accurately identifying autoimmune diseases and aiding in the treatment decisions for patients. Exagen's commitment to innovation and research-driven solutions has positioned them as a prominent player in the field of autoimmune disease diagnostics.
Test panels by Exagen
1 panel offered by this laboratory
AVISE CTD
Blood